一种新型口服抗凝血药物,可用于急性和慢性血栓栓塞性疾病的预防及**
达比加群酯CAS号:211915-06-9
达比加群酯分子式: C34H41N7O5
达比加群酯英文名称: N-[2-[4-[N-(Hexyloxycarbonyl)amidino]phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl]-N-(2-pyridyl)-beta-alanine ethyl ester
达比加群酯英文同义词: Dabigatran etexilate; BIBR-1048MS; BIBR-1048; Pradaxa; ethyl N-[(2-{[(4-{[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate
达比加群酯分子量: 627.7332
达比加群酯沸点: 827.9°C at 760 mmHg
达比加群酯密度: 1.49E-27mmHg at 25°C
达比加群酯闪点: 454.5°C